Atlas Trials

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

Clinical trial NCT07156864 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07156864
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2025-09-01
Primary completion
2025-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.